Molecular events in radiation transformation

Radiation Research

Volumn 155, Issue 1, 2001, Pages 215-221

  Syljuåsen, Randi G ^a,b   Krolewski, Bozena ^a   Little, John B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN P53;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; CELL CYCLE G1 PHASE; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; FIBROBLAST; GENE; GENETICS; MOUSE; MUTATION; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FIBROBLASTS; G1 PHASE; GENES, CDC; GENES, P53; MICE; MICE, INBRED C3H; MUTATION; NEOPLASMS, RADIATION-INDUCED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035218602     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0215:MEIRT]2.0.CO;2     Document Type: Article

References (24)

1. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
2. E. A. Harrington, J. L. Bruce, E. Harlow and N. Dyson, pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl. Acad. Sci. USA 95, 11945-11950 (1998).
3. 1 arrest. Cell 76, 1013-1023 (1994).
4. T. A. Weinert and L. H. Hartwell, The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241, 317-322 (1988).
5. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
6. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551 (1994).
7. 1 block is abolished in human diploid fibroblasts transfected with the human papilloma virus E6 gene: implication of the p53-Cip1/WAF1 pathway. Int. J. Oncol. 6, 233-236 (1995).
8. C. Y. Li, H. Nagasawa, W. K. Dahlberg and J. B. Little, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11, 1885-1892 (1995).
9. 1 phase arrest and p53 function in human tumor cells. Cancer Res. 55, 1842-1846 (1995).
10. + human tumor cells synchronized by mitotic selection. Cancer Res. 58, 2036-2041 (1998).
11. 1 checkpoint control is an early step in carcinogenesis, independent of p53 status. Cancer Res. 59, 1008-1014 (1999).
12. C. A. Reznikoff, J. S. Bertram, D. W. Brankow and C. Heidelberger, Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33, 3239-3249 (1973).
13. M. Terzaghi and J. B. Little, X-radiation-induced transformation in a C3H mouse embryo-derived cell line. Radiat. Res. 36, 1367-1374 (1976).
14. A. R. Kennedy, M. Fox, G. Murphy and J. B. Little, Relationship between x-ray exposure and malignant transformation in C3H10T1/2 cells. Proc. Natl. Acad. Sci. USA 77, 7262-7266 (1980).
15. A. R. Kennedy, J. Cairns and J. B. Little, Timing of the steps in transformation of C3H10T1/2 cells by x-irradiation. Nature 307, 85-86 (1984).
16. B. Krolewski and J. B. Little, Application of denaturing gradient gel blots to detect p53 mutations in X-ray-transformed mouse C3H 10T1/2 clones. Mol. Carcinogen. 7, 190-196 (1993).
17. J. V. Gannon, R. Greaves, R. Iggo and D. P. Lane, Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9, 1595-1602 (1990).
18. M. S. Mendonca, K. L. Howard, D. L. Farrington, L. A. Desmond, T. M. Temples, B. M. Mayhugh, J. J. Pink and D. A. Boothman, Delayed apoptotic responses associated with radiation-induced neoplastic transformation of human hybrid cells. Cancer Res. 59, 3972-3979 (1999).
19. B. Paquette and J. B. Little, Genomic rearrangements in mouse C3H/ 10T1/2 cells transformed by X-rays, UV-C, and 3-methylcholanthrene, detected by a DNA fingerprint assay. Cancer Res. 52, 5788-5793 (1992).
20. C. S. Selvanayagam, C. M. Davis, M. N. Cornforth and R. L. Ullrich, Latent expression of p53 mutations and radiation-induced mammary cancer. Cancer Res. 55, 3310-3317 (1995).
21. B. Krolewski and J. B. Little, Overexpression of p21 protein in radiation-transformed mouse 10T1/2 cell clones. Mol Carcinogen. 27, 141-148 (2000).
22. J. M. Jung, J. M. Bruner, S. Ruan, L. A. Langford, A. P. Kyritsis, T. Kobayashi, V. A. Levin and W. Zhang, Increased levels of p21WAF1/ Cip1 in human brain tumors. Oncogene 11, 2021-2028 (1995).
23. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
24. WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. Cancer Res. 58, 5053-5056 (1998).